These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 8530650

  • 1. Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days.
    Baird DT, Thong KJ, Hall C, Cameron ST.
    Hum Reprod; 1995 Sep; 10(9):2270-6. PubMed ID: 8530650
    [Abstract] [Full Text] [Related]

  • 2. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [Abstract] [Full Text] [Related]

  • 4. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST, Thong KJ, Baird DT.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [Abstract] [Full Text] [Related]

  • 5. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 6. Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.
    McCartney CR, Blank SK, Marshall JC.
    Endocrine; 2009 Oct; 36(2):239-45. PubMed ID: 19609733
    [Abstract] [Full Text] [Related]

  • 7. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
    Heikinheimo O, Gordon K, Lähteenmäki P, Williams RF, Hodgen GD.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
    [Abstract] [Full Text] [Related]

  • 8. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM, Randolph JF, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [Abstract] [Full Text] [Related]

  • 9. Use of a GnRH antagonist in conjunction with low amplitude, high frequency LH pulses to induce follicular growth without an LH surge and ovulation in ewes.
    Dobson H, Campbell BK, Scaramuzzi RJ.
    Anim Reprod Sci; 1997 Apr; 46(3-4):213-22. PubMed ID: 9231261
    [Abstract] [Full Text] [Related]

  • 10. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J, Kooistra HS, Djajadiningrat-Laanen SC, Dieleman SJ, Okkens AC.
    Theriogenology; 2006 Apr 15; 65(7):1346-59. PubMed ID: 16197989
    [Abstract] [Full Text] [Related]

  • 11. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM, Lunn SF, Morris KD, Deghenghi R.
    Hum Reprod; 1997 Mar 15; 12(3):430-5. PubMed ID: 9130734
    [Abstract] [Full Text] [Related]

  • 12. Alteration of gonadotrophin and steroid hormone release, and of ovarian function by a GnRH antagonist in gilts.
    Brüssow KP, Schneider F, Nürnberg G.
    Anim Reprod Sci; 2001 Apr 30; 66(1-2):117-28. PubMed ID: 11343847
    [Abstract] [Full Text] [Related]

  • 13. Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone.
    Messinis IE, Lolis D, Zikopoulos K, Tsahalina E, Seferiadis K, Templeton AA.
    Hum Reprod; 1994 Aug 30; 9(8):1437-41. PubMed ID: 7989501
    [Abstract] [Full Text] [Related]

  • 14. The steroid antagonist RU486 given at pro-oestrus induces hypersecretion of follicle-stimulating hormone from oestrus afternoon to early metoestrus in the rat.
    Sánchez-Criado JE, Tébar M, Ruiz A, Padrón L.
    Eur J Endocrinol; 1997 Sep 30; 137(3):281-6. PubMed ID: 9330593
    [Abstract] [Full Text] [Related]

  • 15. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms.
    Attardi B, Scott R, Pfaff D, Fink G.
    J Neuroendocrinol; 2007 Dec 30; 19(12):988-1000. PubMed ID: 18001329
    [Abstract] [Full Text] [Related]

  • 16. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE, Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K, Lolis D.
    Hum Reprod; 1998 Sep 30; 13(9):2415-20. PubMed ID: 9806260
    [Abstract] [Full Text] [Related]

  • 17. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.
    Adams JM, Taylor AE, Schoenfeld DA, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 1994 Sep 30; 79(3):858-64. PubMed ID: 7521353
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb 30; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 19. Effect of mifepristone on folliculogenesis in women treated with recombinant FSH.
    Messinis IE, Krishnan M, Kazem R, Khadilkar S, Templeton AA.
    Clin Endocrinol (Oxf); 1997 Mar 30; 46(3):309-14. PubMed ID: 9156040
    [Abstract] [Full Text] [Related]

  • 20. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J, De Vits A, Joostens M, Van Royen E.
    Hum Reprod; 1995 Jan 30; 10(1):56-62. PubMed ID: 7745071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.